Orin Hirschman 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-27 10:07 am Sale | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 2,022,221 4.900% | -640,103 (-24.04%) | Filing |
| 2024-02-07 6:58 pm Purchase | 2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 2,662,324 8.700% | 747,104 (+39.01%) | Filing |
| 2023-12-05 06:01 am Purchase | 2023-11-07 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 1,915,220 9.900% | 1,915,220 (New Position) | Filing |